Integrated DNA Technologies

Integrated DNA Technologies (IDT), founded in 1987 and headquartered in Coralville, Iowa, is a premier supplier of custom nucleic acids. The company serves critical sectors including academic research, biotechnology, clinical diagnostics, and pharmaceutical development. IDT specializes in the development, manufacturing, and marketing of advanced nucleic acid products essential for life science innovation. Its comprehensive portfolio includes custom nucleic acids, genomic tools, synthetic DNA, primers, and probes, underpinning advancements in gene editing, sequencing, and disease research. The company's commitment to accuracy and reliability positions it as a key player in the scientific community, focusing on B2B markets.

Operating with a workforce of 1,000-5,000 employees across 16 locations, IDT demonstrates substantial operational scale. This extensive network supports its mission to provide high-quality synthetic DNA and related products globally. The company's expertise in DNA technology is crucial for researchers and developers pushing the boundaries of molecular biology and diagnostics. For insights into the people driving these innovations, one can Meet Integrated DNA Technologies' team. Their contributions are vital to the company's ongoing success and its role in advancing scientific discovery and therapeutic development.

IDT competes in a dynamic market alongside entities such as New England Biolabs, GENEWIZ, Sino Biological, and Promega. With a reported revenue of $654.5 million, the company maintains a strong financial standing within the pharmaceuticals and healthcare industries. Its strategic focus on specialized genomic and cancer research panels underscores its market position. The company's long history, dating back to 1987, reflects its sustained impact and evolution in the life sciences sector.